Several secondary metabolites from actinomycetes have recently been found to inhibit proliferation of cultured animal cells by blocking the cell cycle progression in Gl and G2 phases1~4). Leptomycin B is one of such compoundspossessing a unique structure of a long branched dicarboxylic acid, in which one carboxyl group formed a (5-lactone ring3 '5'6) .
In the course of our screening program for the gap phase-specific inhibitors of the mammaliancell cycle, we found that Streptomyces sp. SAM1 595 produced an active substance whosestructure was similar to leptomycins but contained a primary alcoholic group instead of one of the two carboxyl groups. The compoundwas named leptolstatin according to the structural similarity to leptomycins. Taxonomy of the producing strain, fermentation, purification, and biological activities have been reported in the preceding paper1}. This paper deals with the physico-chemical properties and structural elucidation of leptolstatin.
Materials and Methods
The UV and IR spectra were recorded on a Shimadzu UV-240 and a NICOLET7199 (FT)-IR spectrometer, respectively. The lH NMR(500MHz) and 13C NMR(67.8 MHz) spectra were obtained with a General Electric GN-500 FT NMRspectrometer and a JEOL EX-270 FT NMRspectrometer, respectively. The fast atom bombardment mass spectra (FAB-MS) were measured with a JEOL HX1 10 spectrometer using 2,2-dithiodiethanol as the matrix.
Results and Discussion
Physico-chemical properties of leptolstatin are summarized in C-8Et (Tables 1 -3 ).
Since the UV (Table 1) , XH NMRand IR spectra ( Figs. 1 and 2 ) of leptolstatin resembled those of leptomycin B5), leptolstatin is supposed to possess a structure similar to those of leptomycins.
To determine the structural difference between leptomycin B and leptolstatin, we compared *H NMRand 13C NMRspectral data of these compounds (Tables 2 and 3 ). In the 13C and XHNMRspectra of leptolstatin, a new methylene signal was observed at Sc 30.1 and SH 2.47 in place ofa methine (3C 33.6, Sn 2.53) and methyl signals at C-4 (Sc 12.3, 3n 1.06) found in the spectrum of leptomycin B, indicating that the C-4 position of leptolstatin is demethylated. In addition, a vinylic methyl group (Sc 20.3, dH 1.83) was newly observed in leptolstatin instead of the C-8 ethyl group of leptomycin B. Furthermore, a new methylene signal (dc 59.2, SH 4.16) was detected in place of the C-24 tertiary carbon signal, suggesting that leptolstatin contains a hydroxymethyl group instead of the terminal carboxyl group of leptomycin B. The IR spectrum of leptolstatin supported the absence of the carboxyl group (Fig. 2) . These data indicate that leptolstatin is a new leptomycin B analogue, in which the C-4 position is demethylated and the C-8 ethyl and the terminal carboxyl groups are replaced by the methyl and the hydroxymethyl groups, respectively. This structure was further confirmed by 2D correlation spectroscopy (COSY) (Fig. 3) .
In the previous studies on leptomycins and other related compounds, geometry of a double bond between C-8 and C-9 had not yet been determined Weanalyzed the configuration in the structure oi leptolstatin by nuclear Overhauser enhancemeni (NOE). As the NOEsignals were observed betweer 9-H and 8-CH3 as well as 6-H and 8-CH3, the doubk bond between C-8 and C-9 was assigned as a Z forir (Fig. 4) . Thus we concluded that the structure o] leptolstatin was (2Z, 6£, 8Z, /2£, 14£, 22£>19, 10, 14, 16, 18, 20, 6, 8, 12, 14, as shown in Fig. 5. Six antibiotics structurally related to leptolstatin have so far been reported, namely leptomycins A and B5>6) (PD 1 14,7207), CI-9407), elactocin7), CL-1957A8), jildamycin9), matuamycin9)), kazusamycins A and B10) (PD 114,7217), hydroxyelactocin7), CL-1957E11}) , and anguinomycins A and B12), all of which possess a terminal carboxyl group (Fig. 5) . Leptolstatin is a novel memberof this class of related compounds with a unique structure in which the terminal carboxyl group is replaced by a hydroxymethyl group. Previous studies by means of chemical modification of kazusamycins showedthat the terminal carboxyl group was necessary for the activity because methyl esterified kazusamycin at the terminal carboxyl group possessed only weak activity13). However, the present study suggests that the terminal carboxyl group is non-essential for the expression of the biological activity. An alternative possibility is the oxidation of the hydroxymethyl group of leptolstatin after incorporation into the cells, thereby leptolstatin is converted to an active form possessing a terminal carboxyl group. The NOEstudy showed that a double bond between C-8 and C-9 ofleptolstatin was a Z form, which had not been assessed in the case of leptomycins or other compounds.A similar NOEanalysis was performed on leptomycin B, and the corresponding double bond was also found to be Z (data not shown). It therefore seems highly probable that all the membersbelonging to this group possess the identical skeleton with a Z form at C-8/C-9, which can be determined by the NOEanalysis.
